Depression

Caplyta is now FDA-approved for depressive episodes from bipolar I and II.

Data from a clinical program evaluating the efficacy and safety of zuranolone was presented at the American College of Neuropsychopharmacology Congress. What new developments did they share?

Research also shows increased prevalence of social risks and unmet social needs.

How can transcranial magnetic stimulation help patients with treatment-resistant depression?

Treatment-resistant depression: how to diagnose, what treatment options are available, and how to best help patients.

What is the connection between inflammation and mood disorders?

How can we improve treatment response? Look to the patient.

Loss and suffering can be hard for both patient and provider. Here’s what we know, what we need to learn, and how to protect yourself as a clinician.

What's new and noteworthy in children and adolescent psychiatry?

Results suggest that psilocybin therapy may prove to be helpful in improving quality of life for patients with cancer.

Larger cities may provide a protective buffer against developing depression. 

New Drug Application to be submitted for MDD in late 2022, with separate filing for PPD planned for early 2023. 

Sidney Zisook, MD, shares insights into defining depression diagnosis.

Bringing science to the practice of psychiatry has been the personal goal of Sheldon H. Preskorn, MD—the Educator of the Year.

Caplyta shows promise as a monotherapy for patients with bipolar I or bipolar II disorder experiencing a major depressive episode

At the Annual Psychiatric Times World CME Conference, an all-star lineup of presenters will share their latest research. Check out this preview of the full agenda.

What can be done to help patients turn painful memories into opportunities for posttraumatic growth?

A hypnotic might be a good option for augmenting depression treatment, but which hypnotic has the best evidence for efficacy?

After a string of disappointing results, mirtazapine gets another look in a recent study.

How can clinicians distinguish between ordinary grief, depression, and prolonged grief disorder?

What toll does trauma take on police officers, firefighters, and EMT workers?

What are the risk factors for and prevalence overweight and obesity in patients with first-episode drug-naïve major depressive disorder?

A clinical review of an effective approach for treatment-resistant depression.

What will psychiatric practice look like in the year 2030?

Could the emerging field of epigenetics hold the key to catching postpartum depression before it happens?

What are the greatest unmet mental health needs in the United States today? Recent statistics from the Centers for Disease Control may hold the answers.

A rare robust finding from a study on bipolar depression.

If approved, SLS-002 would be only the second approved product for ASIB.

Apathy occurs throughout the spectrum of neurocognitive disorders, but it is easy to mistake for other conditions, like depression. How can clinicians identify apathy, and treat it?

Research confirms COVID-19’s negative impact on Americans’ mental health.